• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23533 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical Practice Guideline on the care for people with alzheimer's disease and dementia]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on the diagnostic, treatment and prevention of tuberculosis]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on the management of head injury in the field of extra and initial hospital care]
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on the management of vasomotor and vaginal symptoms associated with menopause and postmenopause]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on type 1 diabetes]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on type 2 diabetes]
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guidelines for hemotherapy. Brief report]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guidelines on arterial hypertension (2007 update)]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guidelines on lipid management as a cardiovascular risk factor]
2018     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guidelines on severe mental disorder]
2020     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guidelines on the diagnosis and treatment of non-serious blunt chest trauma]
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [Clinical safety and effectiveness of robotic surgery (2)]
2021     Andalusian Health Technology Assessment Area (AETSA) [Clinical utility of optical coherence tomography angiography in exudative age-related macular degeneration management]
2013     Haute Autorite de sante (HAS) [Clinical utility of the measurement of vitamin D]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Clinically relevant venous thromboembolism following hip and knee arthroplasty]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clonidine: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clopidogrel plus acetylsalicylic acid in acute coronary syndrome]
2006     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clopidogrel versus acetylsalicylic acid for the secondary prevention of vascular diseases]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clopidogrel, prasugrel, and ticagrelor for the prevention of atherothrombotic events in acute coronary syndrome]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [CO2 Laser surgery in patients with otosclerosis]
2009     Committee for New Health Technology Assessment (CNHTA) [CoaguChek XS PT TEST]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobicistat (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobimetinib - Benefit assessment according to §35a Social Code Book V]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobimetinib: addendum to commission A15-52]
2008     Center for Medical Technology Assessment (CMT) [Cognitive assistive technologies for persons with dementia - cost-effectiveness and quality of prescription process]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cognitive behavioural therapy for insomnia - Evidence report for the S3 guideline on non-restorative sleep/sleep disorders - Insomnia in adults]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cognitive behavioural therapy: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Cognitive rehabilitation in cognitive deficit secondary to stroke]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Cognitive rehabilitation in secondary cognitive impairment]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Coherent monitoring and follow-up of pregnant women with a heart disease - a Health Technology Assessment]
2008     Committee for New Health Technology Assessment (CNHTA) [COL2A1 gene, mutation[sequencing]]
2008     Committee for New Health Technology Assessment (CNHTA) [COL3A1 gene mutation analysis]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cold plasma in wound therapy (2nd addendum to Commission E21-03)]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cold plasma in wound therapy (Addendum to Commission E21-03)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cold plasma in wound therapy]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Colestilan - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Collaboration Research for development of Trustworthy Clinical Practice Guidelines and evaluation of implementation]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Collagen-covered and periosteum-covered autologous chondrocyte implantation in the knee joint as well as matrix-associated autologous chondrocyte implantation in the knee joint]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Colon cancer investigation, treatment and follow-up algorithm (update)]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Colon examination with CT colonography - a health technology assessment]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Colongraphy compared with conventional colonoscopy]
2000     Finnish Office for Health Care Technology Assessment (Finohta) [Colorectal cancer screening in Finland: conditions and effects]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Colorectal cancer screening in persons with a relevant family history - Update to commission S11-01]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2023     Institute for Clinical Effectiveness and Health Policy (IECS) [Combination diagnostic tests offered as part of preventive health checks exams in overall population]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Combined screening for early diagnosis of chromosomal abnormalities during the first trimester of pregnancy]
2014     Andalusian Health Technology Assessment Area (AETSA) [Communication strategies with children and adolescents in the hospital or primary care setting]
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Comparative analysis of thermal disinfection with a washer-disinfector and pasteurization: anaesthesia and respiratory devices]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness of carbapenems and alternative antibiotics for the treatment of bacteraemia and/or urinary tract infectious disease by Enterobacteriaceae producing extended-spectrum β-lactamase]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Comparative effectiveness of conservative treatment of breast cancer with brachytherapy and external beam radiation]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness of medication therapies in the rheumatoid arthritis patients]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness research of computer-assisted navigation in knee arthroplasty]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness study of catheter ablation for atrial fibrillation]
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Comparative results of the different screening strategies used for T21, T18 and T13: adaptation of the EUnetHTA assessment]
2024     HTA Region Stockholm [Comparing coronary computed tomography angiography (CCTA) to exercise electrocardiogram for suspected coronary artery disease: impact on patient outcomes]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparison between ICPC (International Classification of Primary Care) classification and ICD (International Classification of Diseases) classification at primary care in Korea]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Complete exome sequencing in epileptic encephalopathy]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Complex wound treatment: negative pressure therapy]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Complications associated with the surgical instruments used in tonsillectomies]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Computed tomography and its carcinogenic effects in children and youth in Québec]
2011     The Swedish Council on Health Technology Assessment (SBU) [Computer-Aided Detection (CAD) in mammography screening]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Computer-assisted minimally invasive total hip surgery (MIS): a randomised controlled trial into the effectiveness compared to traditional total hip arthroplasty (THA)]
2007     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Computer-assisted surgery in knee surgery - a health technology assessment]
2008     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Computer-based cognitive behavioral therapy]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Computerised axial tomography: equipments and use in the ACBC. Instructions on the appropriate use of CAT]
2023     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Computerized clinical decision support systems for decision support in patients with breast, lung, colorectal or prostate cancer]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Computerized physician order entry - effectiveness and efficiency of electronic medication ordering with decision support systems]
2009     The Swedish Council on Health Technology Assessment (SBU) [Computerized training for children with ADHD]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for a national health portal]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection - autologous anti-CD19-transduced CD3+ cells]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – Valoctocogen roxaparvovec: review of the study protocol (version 2.0) and the statistical analysis plan (version 2.0) – 3. Addendum to project A22-20]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV) – exagamglogene autotemcel (beta-thalassaemia)]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV): talquetamab (multiple myeloma)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for brexucabtagene autoleucel acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for etranacogene dezaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for fedratinib acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for risdiplam acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for valoctocogene roxaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV): Evaluation of the study protocol (Version 1.0) and the statistical analysis plan (Version1.0) – Second addendum to Commission A22-20]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for valoctocogene roxaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Concepts of care for people with dementia]
2021     Gesundheit Osterreich GmbH (GOeG) [Concepts, indicators and measurement instruments for recording the impact of anti-stigma measures in mental health - quick assessment]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Conditions for regional implementation of a national careprogramme anxiety disorders, based on the multidisciplinary evidence based guideline on anxiety disorders]
2023     Canary Health Service [Conduction system pacing implantation through electroanatomical mapping-guided vs. fluoroscopy]
2022     HTA South [Conductive education in cerebral palsy]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Conductive intravesical chemohyperthermia with mitomycin in non-muscle invasive bladder cancer: review of guidelines and ongoing research]
2009     Basque Office for Health Technology Assessment (OSTEBA) [Confidentiality of medical records. Analysis of the current situation and areas for improvement in their use and management]
2010     Andalusian Health Technology Assessment Area (AETSA) [Confocal microscopy in ophthalmology: Report summary of emergent technology]
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Congenital hypothyroidism: clinical practice guideline]
2021     Health Sciences Institute in Aragon (IACS) [Congenital ventricular septal defect (VSD) treatment with percutaneous and periventricular insertion devices]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Consensus recommendations on post-traumatic brain injury (TBI) rehabilitation]
2008     Center for Medical Technology Assessment (CMT) [Consequences appearing to family carers]
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) [Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Contaminants from the treatment of drinking water in the Autonomous Community of the Basque Country: Assessment of the risk and alternative treatments]
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Continuity of care]
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Continuous anaesthetic infusion system at the surgical site]
2005     Andalusian Health Technology Assessment Area (AETSA) [Continuous blood glucose monitoring system "GlucoWatch"]